Interestingly, some of the genes, such as angiomotin (AMOT), adenylate kinase 1 (AK1), Musashi RNA binding protein (MSI), signal transducer and activator of transcription (STAT2) and POU class 2 homeobox 2 (POU2F2), were reported before as cancer survival markers [74,75,76,77,78,79,80], whereas other genes, such as F-box and WD repeat domain containing 7 (FBXW7) and choline kinase alpha (CHKA), were found to be regulated by GC treatment [23,71,81]. Here, AMOT is linked to cancer.